44 Pereira Pinto L, de Souza LB, Gordón-Núñez MA, et al. Prevention of oral lesions in children with acute lymphoblastic leukemia. Int J Pediatr Otorhinolaryngol. 2006; 70(11): 1847-51.
45 Chi AC, Neville BW, Krayer JW, Gonsalves WC. Oral manifestations of systemic disease. American Fam Physi. 2010; 82(11):1381-88.
46 Romeo O, Criseo G. Molecular epidemiology of Candida albicansand its closely related yeasts Candida dubliniensis andCandida africana . J Clin Microbiol. 2009; 47:212-4.
47 Romeo O, Criseo G. Candida africana and its closest relatives. Mycoses. 2011; 54:475-86.
48 Romeo O, Criseo G. First molecular method for discriminating betweenCandida africana, Candida albicans and Candida dubliniensis by using hwp1 gene. Diagn Microbiol Infect Dis. 2008; 6:230-3.
49 Odds FC. Molecular phylogenetics and epidemicology of Candida albicans. Future Microbiol. 2010; 5:67-79.
50 Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. J Microbiol Methods 2015; 111:50-56.
51 Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC.Candida dubliniesis sp. nov. : Phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology. 1995; 141:1507-21.
52 Marsh PD, Martin M. “Oral fungal infections”, in Orals Microbiology, Churchill Livingstone, Edinburgh, UK; 2009. pp. 166-179.